多基因风险评分指导的临床模型用于改进腹主动脉瘤筛查
该前瞻性队列研究基于英国生物银行数据,利用911,440个单核苷酸变异计算腹主动脉瘤多基因风险评分(PRSAAA),并开发结合临床变量的Prob-AAA模型。结果显示PRSAAA与Prob-AAA均为 incident AAA 的独立预测因子,Prob-AAA识别出9.6%的 incident AAA 病例,而PRSAAA仅识别4.2%;现行指南仅覆盖5.7%的队列。
要点
- PRSAAA最高十分位组 incident AAA 发生率为0.93%,最低十分位组为0.30%。
- Prob-AAA识别9.6%的 incident AAA 病例,而PRSAAA仅识别4.2%。
核心结论
- Prob-AAA这一基于多基因风险评分的临床模型提升了现行临床危险因素指导的筛查指南对腹主动脉瘤的预测能力。
主要发现
- 共2,668例 incident AAA 病例;PRSAAA从最低十分位到最高十分位, incident AAA 发生率从0.30%升至0.93%。
- 需手术和/或破裂的严重AAA占 incident AAA 病例的比例随十分位从23%升至39%。
- 现行筛查指南覆盖总队列的5.7%,其 incident AAA 率约为3.2%;在未被现行指南纳入的男性中,Prob-AAA额外识别出约占总队列2%的群体,其 incident AAA 率相似。
关键数值与推荐
- PRSAAA基于911,440个单核苷酸变异计算;冠状动脉疾病PRS基于2,324,683个单核苷酸变异计算,均源自混合 ancestry 全基因组关联研究。
临床怎么用
- Prob-AAA模型可用于识别现行筛查指南未覆盖的高危男性个体,以补充腹主动脉瘤筛查。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Abdominal aortic aneurysm (AAA) is a complex disease with environmental and genetic risk factors. Polygenic risk scores (PRSs) based on disease-specific risk-associated single nucleotide variants (SNVs) have demonstrated effectiveness in stratifying individual-level disease risk for cardiovascular diseases. This prospective cohort study assessed associations of PRS of AAA (PRSAAA) with risk of incident AAA, analyzed the effectiveness of a combined clinical-genetic risk model, and explored the clinical utility of the model in identifying high-risk individuals for AAA screening. METHODS: PRSAAA was calculated using 911,440 SNVs and PRS of coronary artery disease was calculated using 2,324,683 SNVs derived from mixed ancestry genome-wide association studies. The UK Biobank was used as the study cohort. All individuals with complete genetic data available and no diagnosis of AAA at the time of recruitment were included in the analysis and followed prospectively to assess for incident AAA. A PRS-informed clinical model, Prob-AAA, was developed using clinically significant variables and PRSAAA. RESULTS: Four hundred eighty-one thousand one hundred 5 individuals were included in the analysis with 2,668 incident AAA cases. Incident AAA increased from 0.30 to 0.93% between the lowest and highest decile of PRSAAA; similarly, severe AAA, requiring surgery and/or presenting with rupture, increased from 23 to 39% of incident AAA cases across deciles. PRSAAA was a predictor of incident AAA diagnosis (hazard ratio 2.06 [1.70-2.48]) independent of other clinical risk factors including male sex, older age, and smoking history. Prob-AAA was an independent predictor of incident AAA (hazard ratio 1.92 [1.69-2.20]), and identified 9.6% of cases of incident AAA compared to only 4.2% by PRSAAA. Current screening guidelines captured 5.7% of the overall cohort, with an incident AAA rate of approximately 3.2%. Among males not included by current guidelines, Prob-AAA identified an additional cohort, approximately 2% of the overall cohort, with a similar rate of incident AAA. CONCLUSIONS: Prob-AAA, a PRS-informed clinical model for AAA, improved upon the predictive power of current, clinical risk factor-informed, screening guidelines for AAA.
引用
- Jiang D, Shi Z, Wei J, et al. Polygenic Risk Score Informed Clinical Model for Improving Abdominal Aortic Aneurysm Screening. Ann Vasc Surg. 2024. PMID: 39067852. doi:10.1016/j.avsg.2024.06.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。